Reviva Pharmaceuticals 4.76M share Secondary priced at $1.05
PremiumThe FlyReviva Pharmaceuticals 4.76M share Secondary priced at $1.05
2M ago
Reviva Pharmaceuticals downgraded to Hold from Buy at Maxim
Premium
The Fly
Reviva Pharmaceuticals downgraded to Hold from Buy at Maxim
3M ago
Reviva Pharmaceuticals announces anticipated milestones
Premium
The Fly
Reviva Pharmaceuticals announces anticipated milestones
3M ago
Reviva Pharmaceuticals price target lowered to $14 from $20 at H.C. Wainwright
PremiumThe FlyReviva Pharmaceuticals price target lowered to $14 from $20 at H.C. Wainwright
5M ago
Reviva Pharmaceuticals Progresses with Global Schizophrenia Trial
Premium
Company Announcements
Reviva Pharmaceuticals Progresses with Global Schizophrenia Trial
6M ago
Reviva announces enrollment update for OLE study on brilaroxazine
Premium
The Fly
Reviva announces enrollment update for OLE study on brilaroxazine
6M ago
Reviva Pharmaceuticals announces FDA alignment on brilaroxazine trial
PremiumThe FlyReviva Pharmaceuticals announces FDA alignment on brilaroxazine trial
7M ago
Reviva Pharmaceuticals: Insights from Latest SEC Report
Premium
Company Announcements
Reviva Pharmaceuticals: Insights from Latest SEC Report
7M ago
Reviva Pharmaceuticals announces anticipated milestones, events
Premium
The Fly
Reviva Pharmaceuticals announces anticipated milestones, events
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100